These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31414352)

  • 1. US ED Opioid-Related Visits Increase, While Use of Medication for Opioid Use Disorder Undetectable, 2011-2016.
    Shastry S; Manini AF; Richardson LD; Lin MP
    J Gen Intern Med; 2020 Mar; 35(3):965-966. PubMed ID: 31414352
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of medications used for opioid use disorder in emergency departments: A cross-sectional analysis of the 2020 National Hospital Ambulatory Medical Care Survey.
    Lee S; Sun L; Vakkalanka JP
    Am J Emerg Med; 2024 Aug; 82():52-56. PubMed ID: 38795424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose.
    Bagley SM; Larochelle MR; Xuan Z; Wang N; Patel A; Bernson D; Silverstein M; Hadland SE; Land T; Samet JH; Walley AY
    Ann Emerg Med; 2020 Jan; 75(1):29-38. PubMed ID: 31591014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy.
    Park TW; Bohnert AS; Austin KL; Saitz R; Pizer SD
    Psychiatr Serv; 2014 Jan; 65(1):4. PubMed ID: 24382761
    [No Abstract]   [Full Text] [Related]  

  • 5. A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.
    Haffajee RL; Andraka-Christou B; Attermann J; Cupito A; Buche J; Beck AJ
    Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):69. PubMed ID: 32928272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Way Forward in the Emergency Department.
    Schwarz ES; Laes JR; Wiegand TJ
    J Med Toxicol; 2019 Oct; 15(4):220-222. PubMed ID: 31278586
    [No Abstract]   [Full Text] [Related]  

  • 7. Managing emergency department patients with opioid use disorder.
    Hazekamp CS; Sacco D
    Emerg Med Pract; 2024 Jun; 26(6):1-24. PubMed ID: 38768011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication-assisted treatment for opioid use disorder.
    Kaplan L
    Nurse Pract; 2019 Mar; 44(3):10-12. PubMed ID: 30585906
    [No Abstract]   [Full Text] [Related]  

  • 9. Medication-Based Treatment to Address Opioid Use Disorder.
    Leshner AI; Dzau VJ
    JAMA; 2019 Jun; 321(21):2071-2072. PubMed ID: 31046072
    [No Abstract]   [Full Text] [Related]  

  • 10. Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.
    Krawczyk N; Mojtabai R; Stuart EA; Fingerhood M; Agus D; Lyons BC; Weiner JP; Saloner B
    Addiction; 2020 Sep; 115(9):1683-1694. PubMed ID: 32096302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of naltrexone in treating opioid use disorder in pregnancy.
    Towers CV; Katz E; Weitz B; Visconti K
    Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance medication for opiate addiction: the foundation of recovery.
    Bart G
    J Addict Dis; 2012; 31(3):207-25. PubMed ID: 22873183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder.
    Davis CS; Carr DH; Glenn MJ; Samuels EA
    Ann Emerg Med; 2021 Jul; 78(1):102-108. PubMed ID: 33781607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid Maintenance Therapy: A Review of Methadone, Buprenorphine, and Naltrexone Treatments for Opioid Use Disorder.
    Fipps DC; Oesterle TS; Kolla BP
    Semin Neurol; 2024 Aug; 44(4):441-451. PubMed ID: 38848746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events.
    Xu KY; Presnall N; Mintz CM; Borodovsky JT; Bhat NR; Bierut LJ; Grucza RA
    JAMA Netw Open; 2021 Feb; 4(2):e210061. PubMed ID: 33625511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone and Buprenorphine Prescribing Following US Emergency Department Visits for Suspected Opioid Overdose: August 2019 to April 2021.
    Chua KP; Dahlem CHY; Nguyen TD; Brummett CM; Conti RM; Bohnert AS; Dora-Laskey AD; Kocher KE
    Ann Emerg Med; 2022 Mar; 79(3):225-236. PubMed ID: 34802772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment.
    Saloner B; Stoller KB; Alexander GC
    N Engl J Med; 2018 Jul; 379(1):4-6. PubMed ID: 29972745
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment for opioid use disorder in the Florida medicaid population: Using a cascade of care model to evaluate quality.
    Johnson K; Hills H; Ma J; Brown CH; McGovern M
    Am J Drug Alcohol Abuse; 2021 Mar; 47(2):220-228. PubMed ID: 33054435
    [No Abstract]   [Full Text] [Related]  

  • 19. Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.
    Stein BD; Saloner B; Schuler MS; Gurvey J; Sorbero M; Gordon AJ
    JAMA; 2021 Jun; 325(21):2206-2208. PubMed ID: 34061152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.
    Connery HS
    Harv Rev Psychiatry; 2015; 23(2):63-75. PubMed ID: 25747920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.